Results 101 to 110 of about 102,003 (257)
We developed an ultrasound‐controlled biomimetic nanoplatform, mRNA/V@M NPs, to co‐deliver CD74 mRNA and V‐9302 for fibrotic TNBC therapy. CD74 mRNA reprograms myCAFs into antigen‐presenting apCAF cells through the CD74‐MHC II pathway, while V‐9302 induces ICD and activates MHC I‐CD8+ T cell immunity.
Chen Ai +9 more
wiley +1 more source
Through AI‐assisted screening from FDA‐approved API to overcome the limitations of bacterial osteomyelitis treatment, glycyrrhizic acid and simvastatin are identified as a multifunctional combination capable of self‐assembling into mechanism‐targeting nanocrystals that effectively neutralize reactive oxygen species, suppress M1 macrophage polarization,
Yu Han +11 more
wiley +1 more source
Quantification of nanoparticle interactions with the Nanoparticle Clearance System [PDF]
The goal of nanomedicine is to target therapeutic and diagnostic agents to target tissues. However, there are multiple physiological barriers which prevent nanoparticles from reaching the desired destination in the body.
Quine, Skyler
core
Engineering‐Modulated Molybdenum Enzymes Strategy for Tumor‐Specific Metabolic‐Immunotherapy
Biodegradable molybdenum sulfide nanoparticles were synthesized via a one‐pot strategy to increase molybdenum enzyme activity and thus effectively potentiate anti‐tumor immunity by integrating molybdenum‐based metalloimmunotherapy with hydrogen sulfide gas therapy.
Xiaoxiao Pan +14 more
wiley +1 more source
Infected diabetic wounds are prone to developing bacterial biofilms and are difficult to treat due to a lack of strategies that can eliminate drug-resistant bacteria.
Sri Ganga Padaga +5 more
doaj +1 more source
Engineering a 660 nm‐Responsive Optogenetic Inducer of Pyroptosis for Precision Cancer Therapy
This study reports a bioorthogonal pyroptosis inducer, PyroRACS. By using a red‐light‐responsive Cre‐On genetic switch to control the expression of highly cytotoxic GSDMDNT, PyroRACS enables the artificial induction of pyroptosis with precise spatiotemporal control.
Mengkai Zhang +5 more
wiley +1 more source
A high‐loading Zn single‐atom nanozyme (ZMG@CS) delivers ML‐SA5 and GOx to lysosomes. ML‐SA5 activates TRPML1 to release endogenous Zn2+, while the nanozyme provides exogenous Zn2+ and GOx‐driven acidification amplifies ROS production. Together, these effects suppress the HIF‐1α/GLUT1 axis, disrupt glucose and redox homeostasis, induce disulfidptosis ...
Zhenxin Wang +12 more
wiley +1 more source
Essential components of a successful doctoral program in nanomedicine
Anne L van de Ven,1,2 Mary H Shann,3 Srinivas Sridhar1,2 1Nanomedicine Science and Technology Center, 2Department of Physics, Northeastern University, Boston, MA, USA; 3School of Education, Boston University, Boston, MA, USAAbstract: The Nanomedicine ...
Sridhar S, van de Ven AL, Shann MH
core
Nanomedicine: promises and challenges for the future of public health
Michelle Pautler, Sara BrennerUAlbany College of Nanoscale Science and Engineering, Albany, NY, USAAbstract: As the scope of nanotechnology applications in medicine evolves, it is important to simultaneously recognize and advance contributions germane to
Sara Brenner, Michelle Pautler
core +1 more source
Antibody‐Empowered Nanomedicine for Precise Biomedical Applications
The advancement of nanotechnology has positioned nanomedicine as powerful tools for disease diagnosis and treatment. However, the clinical efficacy of conventional nanomedicine is often limited by its passive targeting strategies and limited range of ...
Chen Chen +7 more
doaj +1 more source

